Literature DB >> 16728755

Fiscal versus social responsibility: how Philip Morris shaped the public funds divestment debate.

N Wander1, R E Malone.   

Abstract

Calls for institutional investors to divest (sell off) tobacco stocks threaten the industry's share values, publicise its bad behaviour, and label it as a politically unacceptable ally. US tobacco control advocates began urging government investment and pension funds to divest as a matter of responsible social policy in 1990. Following the initiation of Medicaid recovery lawsuits in 1994, advocates highlighted the contradictions between state justice departments suing the industry, and state health departments expanding tobacco control programmes, while state treasurers invested in tobacco companies. Philip Morris (PM), the most exposed US company, led the divestment opposition, consistently framing the issue as one of responsible fiscal policy. It insisted that funds had to be managed for the exclusive interest of beneficiaries, not the public at large, and for high share returns above all. This paper uses tobacco industry documents to show how PM sought to frame both the rhetorical contents and the legal contexts of the divestment debate. While tobacco stock divestment was eventually limited to only seven (but highly visible) states, US advocates focused public attention on the issue in at least 18 others plus various local jurisdictions. This added to ongoing, effective campaigns to denormalise and delegitimise the tobacco industry, dividing it from key allies. Divestment as a delegitimisation tool could have both advantages and disadvantages as a tobacco control strategy in other countries.

Entities:  

Mesh:

Year:  2006        PMID: 16728755      PMCID: PMC2596576          DOI: 10.1136/tc.2005.015321

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  7 in total

1.  Tobacco industry documents: treasure trove or quagmire?

Authors:  R E Malone; E D Balbach
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

Review 2.  Thinking the "unthinkable": why Philip Morris considered quitting.

Authors:  E A Smith; R E Malone
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

3.  Selling off or selling out? Medical schools and ethical leadership in tobacco stock divestment.

Authors:  Nathaniel Wander; Ruth E Malone
Journal:  Acad Med       Date:  2004-11       Impact factor: 6.893

4.  A cognitive scientist looks at Daubert.

Authors:  George P Lakoff
Journal:  Am J Public Health       Date:  2005       Impact factor: 9.308

5.  Youth and violence on local television news in California.

Authors:  L Dorfman; K Woodruff; V Chavez; L Wallack
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

6.  The perimetric boycott: a tool for tobacco control advocacy.

Authors:  N Offen; E A Smith; R E Malone
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

7.  Directly eroding tobacco industry power as a tobacco control strategy: lessons for New Zealand?

Authors:  George Thomson; Nick Wilson
Journal:  N Z Med J       Date:  2005-10-07
  7 in total
  5 in total

1.  Corporate image and public health: an analysis of the Philip Morris, Kraft, and Nestlé websites.

Authors:  Elizabeth Smith
Journal:  J Health Commun       Date:  2012-03-16

Review 2.  Corporate philanthropy, lobbying, and public health policy.

Authors:  Laura E Tesler; Ruth E Malone
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

3.  Making big tobacco give in: you lose, they win.

Authors:  Nathaniel Wander; Ruth E Malone
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

4.  The role of corporate credibility in legitimizing disease promotion.

Authors:  Patricia A McDaniel; Ruth E Malone
Journal:  Am J Public Health       Date:  2008-12-23       Impact factor: 9.308

5.  Multisectoral Actions for Health: Challenges and Opportunities in Complex Policy Environments.

Authors:  Viroj Tangcharoensathien; Orapan Srisookwatana; Poldej Pinprateep; Tipicha Posayanonda; Walaiporn Patcharanarumol
Journal:  Int J Health Policy Manag       Date:  2017-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.